nonat Inc.

nonat Inc. We work for the future

We’re thrilled to announce that nonat Inc. has been selected for the J-starX AI Medical program, led by JETRO in collabo...
04/09/2025

We’re thrilled to announce that nonat Inc. has been selected for the J-starX AI Medical program, led by JETRO in collaboration with Kicker Ventures and Mayo Clinic!
This opportunity will further accelerate our mission to bring innovation to women and children across the world.

このたび nonat Inc.は、JETRO が主導し Kicker Ventures と Mayo Clinic が協力する「J-starX AI Medical Program」に採択されました。
この貴重な機会を通じて、世界中の女性と子どもたちにイノベーションを届ける挑戦をさらに加速してまいります。

https://prtimes.jp/main/html/rd/p/000000238.000071241.html

https://www.jetro.go.jp/news/announcement/2025/67fdc08b3366a5a4.html

ジェトロの海外ネットワークを通じて収集した最新のビジネスニュース・レポートなどをお届けしています。

Our CEO was recently interviewed by Kepple (Japanese only). In the interview, he shared the story behind founding the co...
30/08/2025

Our CEO was recently interviewed by Kepple (Japanese only). In the interview, he shared the story behind founding the company, as well as his strong passion and vision for this business.
For more details, please see the link below.

女性と子どもに特化した医療AI基盤モデルの研究開発を進める株式会社nonatは、プレシリーズAラウンドで総額1.3億円の資金調達を実施した。出資元はジェネシア・ベンチャーズおよびNOBUNAGAキャピタルビレッジ。 調達資金は....

We are pleased to announce that nonat Inc. has raised a total of JPY 130 million (approximately USD 0.9 million) in our ...
28/08/2025

We are pleased to announce that nonat Inc. has raised a total of JPY 130 million (approximately USD 0.9 million) in our Pre-Series A funding.

We express our sincere gratitude to Genesia Ventures and NOBUNAGA Capital for their valuable support and for sharing in our mission.
Moving forward, we are highly committed and engaged in building a better future for women and children around the world.

We are actively hiring and committed to growing our team.
For more details, please see here: https://nonat-home.com/en/careers/

Press Release
https://prtimes.jp/main/html/rd/p/000000006.000134613.html

About nonat Inc.
・JP:https://nonat-home.com/
・EN:https://nonat-home.com/en/

About Genesia Ventures, Inc.
https://www.genesiaventures.com/

About NOBUNAGA Capital Village Co., Ltd.
http://www.nobunaga-capital-village.co.jp/

nonat Inc. has been selected for the ICT Startup League, an acceleration program supported by the Japanese Ministry of I...
14/07/2025

nonat Inc. has been selected for the ICT Startup League, an acceleration program supported by the Japanese Ministry of Internal Affairs and Communications.

We will continue driving our mission to protect the health and future of every woman and baby around the world.

株式会社nonatのプレスリリース(2025年7月14日 14時31分)株式会社nonat、総務省「令和7年度ICTスタートアップリーグ」に採択

09/07/2025

🔬 We're Hiring Student Interns in Tokyo!
Join us at the intersection of healthcare, AI, and hardware.

At nonat Inc., we build AI foundation models for women and children, and develop medical devices that use this technology.
We’re seeking passionate student interns excited about AI and hardware.

Join us onsite in Tokyo for hands-on R&D in the med-tech field!!!

🚀 What You'll Do
(Assignments will be tailored to your interests and skills.)
・Design, implement, and evaluate machine learning models
・Develop and test hardware such as sensor devices and robotics
・Engage in circuit and system-level design

📍 Internship Details
・Location: Tokyo, Japan (5-minute walk from Ebisu Station)
・Format: Onsite (in-person attendance required)
・Duration: Flexible (long-term interns welcomed)
・Compensation: Based on experience and skills
・Tools: Python, PyTorch, Arduino, etc.

🎯 Ideal Candidate
・Background in machine learning and/or deep learning
・Programming experience (e.g., Python, C, C++)
・Interest or experience in electronics, robotics, or IoT
・Hands-on mindset and a strong desire to learn

📩 How to Apply
If you're interested, please send us:
・A brief self-introduction
・A summary of past projects or relevant experience (GitHub/portfolio links welcome)
→ via email at careers@nonat.co.jp

🏢 About nonat
nonat is a startup building medical technology for women and children through innovation.
Learn more: https://nonat-home.com

We’re delighted to share that our CEO was interviewed by his prestigious alma mater (LSHTM) in recognition of his signif...
08/04/2025

We’re delighted to share that our CEO was interviewed by his prestigious alma mater (LSHTM) in recognition of his significant multidisciplinary career milestone—coinciding with World Health Day!

Together as one team, we remain committed to accelerating our project to protect the lives of mothers and babies across generations through AI-driven strategies. We look forward to sharing more exciting news soon!

https://www.linkedin.com/posts/london-school-of-hygiene-%26-tropical-medicine-cp_worldhealthday-health-maternal-activity-7314972490743599107-ZTTe?utm_source=share&utm_medium=member_desktop&rcm=ACoAADgKJ4YBMh88RiPWJERL3FwOfgJLiHHdHQI

https://www.lshtm.ac.uk/aboutus/alumni/blogs/2025/alumni-profile-keisuke-ito

Can you please tell us a bit about your current work/research?Our ultimate goal is to protect women's and children's lives across generations through technology. We now focus on identifying high-risk

We are very happy to announce that we will present our clinical research findings at the 77th Annual Congress of the Jap...
19/12/2024

We are very happy to announce that we will present our clinical research findings at the 77th Annual Congress of the Japan Society of Obstetrics and Gynecology.
Driven by our commitment to issue-driven innovation in perinatal care, we remain dedicated to advancing the prevention and management of preterm birth and stillbirth.
We very much look forward to engaging in meaningful discussions with leading perinatal experts from around the world.

https://nonat-home.com/en/2024/12/19/presenting-first-clinical-research-findings-at-the-77th-annual-congress-of-the-japan-society-of-obstetrics-and-gynecology/?fbclid=IwY2xjawHQxEBleHRuA2FlbQIxMAABHYq-ANCweXopvd0-AqhwKw-16aGH85E9oTKAThS27pjHt3e3HATVg3Ik8g_aem_UHssBQMkAQIv_QdKq1czfQ

We are pleased to announce that we will be presenting at the 77th Annual Congress of the Japan Society of Obstetrics and Gynecology, scheduled to be held in 2025. At this conference, we will share the findings from our first clinical research study and engage in lively discussions with leading perin...

We are pleased to announce that nonat Inc. (Shibuya, Tokyo) has received approval from the Ethics Review Committee of Gi...
06/07/2024

We are pleased to announce that nonat Inc. (Shibuya, Tokyo) has received approval from the Ethics Review Committee of Gifu University Graduate School of Medicine and has commenced the second clinical study.

Building on the extremely favorable verification results obtained in the first clinical study, this research aims to validate generalizability and develop a highly versatile algorithm.

nonat Inc. is dedicated to the rapid social implementation of our developments to save as many small lives as possible.

株式会社nonatのプレスリリース(2024年7月6日 11時14分)第2回臨床研究を開始(Commencement of the Second Clinical Study)

We are very happy to announce that our company has applied for second clinical trial, with the promising results from th...
02/05/2024

We are very happy to announce that our company has applied for second clinical trial, with the promising results from the first one.
It's always challenging to tackle with the uncertainties in this deep-tech field, facing many struggles and adversities, but it is also very exciting to think "how can we make this world better?", and to demonstrate our "own" solutions with our best colleagues.
We can never let my guard down and will remain committed to our new stages, we hope to share more exciting news in the future.

nonat Inc. has applied for an ethical review of its second clinical study, following the promising results from the first clinical study. This study is expected to expand the generalizability of the previous findings. We are currently preparing for presentations at academic conferences and for publi...

住所

道玄坂1丁目
Shibuya-ku, Tokyo

ウェブサイト

アラート

nonat Inc.がニュースとプロモを投稿した時に最初に知って当社にメールを送信する最初の人になりましょう。あなたのメールアドレスはその他の目的には使用されず、いつでもサブスクリプションを解除することができます。

共有する

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

カテゴリー